Scientists at CSIRO’s state-of-the-art biologics production facility in Melbourne work on producing and scaling-up The University of Queensland's (UQ) vaccine candidate for COVID-19.
Working with bioengineered mammalian cells, CSIRO’s fermentation biology team produces and scales-up vaccines – from the laboratory to pilot-scale – in line with best practice manufacturing standards.
Scientists at CSIRO’s state-of-the-art biologics production facility in Melbourne work on producing and scaling-up The University of Queensland's (UQ) vaccine candidate for COVID-19.
Scientists at CSIRO’s state-of-the-art biologics production facility in Melbourne work on producing and scaling-up The University of Queensland's (UQ) vaccine candidate for COVID-19.
Working with bioengineered mammalian cells, CSIRO’s fermentation biology team produces and scales-up vaccines – from the laboratory to pilot-scale – in line with best practice manufacturing standards.
Working with bioengineered mammalian cells, CSIRO’s fermentation biology team produces and scales-up vaccines – from the laboratory to pilot-scale – in line with best practice manufacturing standards.
We have received your enquiry and will reply soon.
We're Sorry
The contact form is currently unavailable. Please try again later. If this problem persists, please call us with your enquiry on 1300 363 400 or +61 3 9545 2176. We are available from 9.00 am to 4.00 pm AEST Monday - Friday.
